Dylan Lewis Cfa, Cpa, Ca

Associate Director, SEC Reporting & Technical Accounting at Lyell Immunopharma

Dylan Lewis, CFA, CPA, CA has a diverse work experience spanning various roles in different companies. Dylan is currently working at Lyell Immunopharma as a Manager, SEC Reporting & Technical Accounting since November 2021. Prior to this, Dylan worked at Core-Mark International for five years as a Technical Accounting Lead, where they were responsible for researching and producing US GAAP memos on various topics and working with internal and external teams. Dylan also provided recommendations for management on accounting projects. Before Core-Mark International, Dylan held the position of Senior Accountant at KPMG from 2012 to 2015. Dylan started their career at Phillips, Hager & North Investment Management as an Institutional Portfolio Administrator Assistant from 2009 to 2011, and previously worked as a Credit Assistant II at Roynat Lease Finance from 2007 to 2009. With their extensive background, Dylan brings a wealth of knowledge and experience to their current role.

Dylan Lewis, CFA, CPA, CA began their education journey in 2000, attending The University of British Columbia where they studied Biology. Dylan completed their Bachelor of Science degree in Biology in 2006. Following this, they pursued a Diploma of Accounting from The University of British Columbia, which they completed in 2011.

In 2008, Dylan enrolled in the CFA Institute to further their education in the field of Finance. Although no specific degree was mentioned, it can be inferred that they underwent coursework or programs related to Finance at the CFA Institute until 2010.

In terms of additional certifications, Dylan obtained their CPA, CA from CPA Canada (Chartered Professional Accountants Canada) in November 2015. Dylan later obtained the Chartered Financial Analyst (CFA) designation from the CFA Institute in September 2016. These certifications highlight their expertise and knowledge in both accounting and finance.

Links